Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation [NA]
This clinical trial update reports on the use of cryoballoon pulmonary venous isolation for patients referred for ablation of typical atrial…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Comparison of Oxygen Interventions and Defibrillator Efficiency [NA]
A clinical trial comparing oxygen interventions and the efficiency of defibrillators in patients with atrial fibrillation and atrial flutter…
-
CLINICAL_TRIALS withdrawal · 2018-05-17Clinical Trial Update: Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures [NA]
The trial evaluating the EPD D700 System for atrial flutter ablation has been withdrawn, with no results reported.
-
FDA approval · 2018-04-10FDA Approved: DOFETILIDE — Original Application (Bionpharma Inc.)
FDA approved a generic version of dofetilide (brand Tikosyn) from Bionpharma Inc. under ANDA208625 for atrial fibrillation and atrial flutte…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery [Phase 3]
Phase 3 clinical trial evaluating a prophylaxis to reduce postoperative atrial fibrillation in cardiac surgery completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-03-26FDA Approved: DOFETILIDE — Original Application (Sigmapharm Laboratories, LLC)
FDA approved the original application for dofetilide from Sigmapharm Laboratories, allowing a generic version of this antiarrhythmic to be m…
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter [NA]
This trial update reports the completion and results posting of a clinical study evaluating the Blazer Open-Irrigated Catheter for treatment…
-
FDA approval · 2017-12-13FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride filed by Hospira, Inc., signaling an additional approval related to the …
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Dipole Density Mapping of Typical Atrial Flutter [NA]
Clinical trial update indicating completion of a study evaluating dipole density mapping for typical atrial flutter. Sponsor: Acutus Medical…
-
FDA approval · 2017-11-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for verapamil hydrochloride from Chartwell RX, LLC.
-
FDA approval · 2017-11-03FDA Approved: FLECAINIDE ACETATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the original application for flecainide acetate by Rising Pharma Holdings, Inc., providing a generic antiarrhythmic product. In…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter [Phase 3]
A Phase 3 trial compares different ablation approaches to determine outcomes in patients with coexisting atrial fibrillation and atrial flut…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: The Contact-CTI Study: Use of Tissue Contact Data to Guide Atrial Flutter Ablation [Phase 4]
The Contact-CTI study evaluated using tissue contact data to guide atrial flutter ablation in a Phase 4 trial, which has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter [Phase 2]
Phase 2 trial updating the pharmacokinetics and safety of MK-4448 in participants with atrial fibrillation or atrial flutter has been comple…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism [Phase 4]
Phase 4 trial update evaluating dabigatran etexilate for prevention of stroke and thromboembolism in atrial fibrillation and atrial flutter.
-
FDA approval · 2017-09-08FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Propafenone hydrochloride generic product under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Thermocool SF Catheter Versus Thermocool Catheter in Isthmus-dependent Atrial Flutter Ablation [Phase 3]
Phase 3 trial comparing Thermocool SF Catheter to Thermocool Catheter for isthmus-dependent atrial flutter ablation has completed.
-
CLINICAL_TRIALS research · 2017-08-09Clinical Trial Update: Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control [Phase 4]
A randomized Phase 4 trial comparing diltiazem with metoprolol for rate control in atrial fibrillation and atrial flutter; the current statu…
-
FDA approval · 2017-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Zydus Pharmaceuticals USA's original application for diltiazem hydrochloride as a generic product, enabling its use for the man…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Ankle - Brachial Index Measurement in Atrial Fibrillation [NA]
A completed clinical trial evaluating ankle-brachial index measurement in patients with atrial fibrillation and atrial flutter; results have…
-
FDA approval · 2017-06-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's diltiazem hydrochloride as a generic product under an original ANDA.
-
FDA approval · 2017-05-05FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: IntellaTip MiFi XP Ablation Catheter Trial [NA]
The trial evaluating the IntellaTip MiFi XP Ablation Catheter for atrial flutter has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography
This trial compares intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation or atrial flutt…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter [NA]
The trial investigating pulmonary vein isolation to reduce future atrial fibrillation risk in patients with typical atrial flutter has been …